The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of the MET inhibitor tivantinib + cetuximab versus cetuximab alone in patients with recurrent/metastatic head and neck cancer.
 
Everett E. Vokes
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Celgene; Clovis Oncology; Eisai; GeneCentric; Genentech; Lilly; Merck; Synta; Transgene; VentiRx
 
Francis P. Worden
Consulting or Advisory Role - Bayer/Onyx
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bayer/Onyx; Bristol-Myers Squibb
 
Douglas Adkins
Research Funding - AstraZeneca; Celgene; Galera Therapeutics; GlaxoSmithKline; Lilly; Novartis; Pfizer; Soligenix; VentiRx
 
Julie E. Bauman
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - AVEO; Bristol-Myers Squibb; Genentech; Incyte; Lilly; Novartis
 
Dean Lim
No Relationships to Disclose
 
Ammar Sukari
No Relationships to Disclose
 
Krishna A. Rao
No Relationships to Disclose
 
Stephanie Ann Wagner
No Relationships to Disclose
 
Kelly Kevelin Curtis
Travel, Accommodations, Expenses - MedImmune
 
Barbara J. Gitlitz
No Relationships to Disclose
 
Katharine Andress Rowe Price
No Relationships to Disclose
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Celgene; Seagen
 
Victoria Meucci Villaflor
No Relationships to Disclose
 
Jonas A. De Souza
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Dendreon; Johnson & Johnson; medpacto; Merck; Millennium; Novartis; Roche/Genentech; Veridex
Consulting or Advisory Role - Bayer; CVS Caremark; Dendreon; Genentech/Roche; Medivation; medpacto; Millennium; Novartis; Sotio; Veridex
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - UpToDate
 
Tanguy Y. Seiwert
Honoraria - Bayer/Onyx; Merck; Novartis
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)